- Home
- GORV vs COEP Comparison
GORV vs COEP Comparison
Compare GORV & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GORV
- COEP
- Stock Information
- Founded
- GORV 1976
- COEP 2017
- Country
- GORV United States
- COEP United States
- Employees
- GORV N/A
- COEP N/A
- Industry
- GORV Retail-Auto Dealers and Gas Stations
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GORV Consumer Discretionary
- COEP Health Care
- Exchange
- GORV Nasdaq
- COEP Nasdaq
- Market Cap
- GORV 25.3M
- COEP 27.4M
- IPO Year
- GORV 2015
- COEP N/A
- Fundamental
- Price
- GORV $6.40
- COEP $10.96
- Analyst Decision
- GORV Hold
- COEP
- Analyst Count
- GORV 2
- COEP 0
- Target Price
- GORV $2.00
- COEP N/A
- AVG Volume (30 Days)
- GORV 80.2K
- COEP 39.2K
- Earning Date
- GORV 08-15-2025
- COEP 08-15-2025
- Dividend Yield
- GORV N/A
- COEP N/A
- EPS Growth
- GORV N/A
- COEP N/A
- EPS
- GORV N/A
- COEP N/A
- Revenue
- GORV $767,257,000.00
- COEP $62,874.00
- Revenue This Year
- GORV $15.65
- COEP N/A
- Revenue Next Year
- GORV $20.54
- COEP N/A
- P/E Ratio
- GORV N/A
- COEP N/A
- Revenue Growth
- GORV N/A
- COEP N/A
- 52 Week Low
- GORV $3.95
- COEP $2.31
- 52 Week High
- GORV $106.80
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- GORV 47.08
- COEP 64.36
- Support Level
- GORV $6.49
- COEP $7.25
- Resistance Level
- GORV $8.15
- COEP $10.00
- Average True Range (ATR)
- GORV 0.78
- COEP 0.52
- MACD
- GORV -0.01
- COEP 0.27
- Stochastic Oscillator
- GORV 34.50
- COEP 93.91
About GORV Lazydays Holdings Inc.
Lazydays Holdings Inc operates recreational vehicle dealerships. It provides products and services for RV owners and outdoor enthusiasts. The company generates revenue by providing a full spectrum of RV products: New and pre-owned RV sales, RV parts and services, financing and insurance products, third-party protection plans, after-market parts and accessories, and RV camping facilities.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.